SPP1 and metabolic dysfunction-associated steatotic liver disease: In experimental models of NAFLD, the inhibition of OPN expression has been shown to significantly reduce both liver inflammation and fibrosis, providing strong evidence of the pivotal role of OPN in mediating liver damage.